Minulý měsíc byl vydán Python 3.15, který přináší malé změny ve vlastním jazyce (nové specifické klíčové slovo), úpravy ...

Want to make your SaaS AI-ready? Discover how to build, test, and deploy an MCP server that connects your app to AI agents.

Phase 1 data from Generate Biomedicines’ ongoing chronic obstructive pulmonary disease study demonstrated “rapid and sustained reductions” across four disease biomarkers. AI-driven Generate ...

AI video generators help you turn your prompts into believable videos, complete with audio. We've tested all the top services to help you choose the one that does the best job with the fewest tweaks.

Your browser does not support the audio element. Coding geometric patterns is a classic milestone for any programmer. It transitions your mind from thinking in linear ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Docs rot faster than fruit. You refactor a function signature on Monday. The docs still show the old signature on Friday. By next month, half your documentation is lying to your users. Formatting is ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...